12-13 May | Amsterdam

Manage supply chain risks with smarter, greener and faster clinical supplies

Name: Clinical Trial Supply
Start: 2026-05-12
End: 2026-05-13

DOWNLOAD AGENDA

BOOK YOUR TICKET

PARTNER OPPORTUNITIES

An effective clinical trial supply chain ensures the right product reaches the right patient, in the right quantity, at the right time. Enabling trials to run smoothly, ethically, and efficiently. The global clinical trial supplies market is set to reach $8.18 billion by 2030, growing at 8.9% annually. This growth is driven by rising pharmaceutical and biotech R&D investment, expanding drug pipelines, the prevalence of complex diseases, and the shift towards decentralised and adaptive trial designs.

However, despite the impressive growth, the clinical trial supply chain faces ongoing challenges: inaccurate demand forecasting, complex global distribution, temperature-sensitive logistics, and limited real-time visibility. These issues are fuelling the need for smarter, faster, and greener supply chains.

Pharma IQ has listened to these concerns and is proud to present the Clinical Trial Supply Forum, designed to tackle clinical trial supply chain challenges head-on. The conference features dedicated streams covering risk management, logistics, packaging, labelling, and storage, providing actionable insights to make every part of the supply chain smarter, greener and faster.

VIEW EARLY AGENDA

Why Attend CTS 2026?

A Sharper Focus on Smarter, Faster, Greener Supply Chains

Dive deeper into how organisations can optimise every step of the supply chain - from packaging and labelling innovation to storage solutions, logistics efficiency, and sustainability strategies.

Open-Access Workshops

Practical workshops, open to all, will provide hands-on insights, real-world case studies, and opportunities to engage directly with specialists.

A Re-imagined Event Format

This year introduces a streamed programme designed to deliver a more cohesive narrative around the end-to-end clinical trial supply chain. Follow curated content streams tailored to your role, priorities, and levels of expertise.

More Meaningful Networking

The event will feature intimate peer-to-peer networking opportunities, designed to encourage open dialogue, problem-solving and relationship-building in smaller, high-value groups.

Our 2026 Expert Speaker Panel Includes

Kamal Amin

Head of Supply Management

Galderma

Samantha Carmichael

Lead Pharmacist Clinical Trials

NHS Greater Glasgow and Clyde

Claudio Semeraro

Director, Head of Candidates and Assets Supply

UCB

Steven Jacobs

President

Global BioPharm Solutions, LLC

Karen Crooks

Associate Director, Clinical Supply Chain

IO Biotech

Peter Sas

Associate Director Compliance & Continuous Improvement

Johnson & Johnson

Kimi Le

Head of Clinical Trial Supply

Immunic Therapeutics

Miguel Silva

Clinical Trials Supply Chain Manager

Eli Lilly & Company

Wil Cools

Clinical Supply leader

Galapagos

Raffaella Fallone

Clinical Data Management & Clinical Supply Lead

Angelini Pharma

Alessandro Amato

Clinical Supply Support

Angelini Pharma

Catherine Crespin

Clinical Labelling & Packaging Supply Lead

UCB

Audrey Aubert

Clinical Supply Compliance Process & Governance Lead

UCB

Chiara Venuti

Member of the Management Board

Cool Chain Association

View All Speakers

Peer-to-Peer Learning and Networking Guaranteed With:

75+

HOURS RESEARCHING WITH INDUSTRY

100+

ATTENDEES

20+

SPEAKERS

WORKSHOPS

HOURS OF NETWORKING OPPORTUNITIES

EXPLORE MORE IN THE AGENDA

Key Focus Areas Include:

Strategic Planning

Optimizing supply chain operations to anticipate and adapt to trial complexities and patient needs.

The Role of Technology

Leveraging digital tools and data analytics to streamline processes, improve forecasting, and enhance end-to-end visibility.

Environmentally Sustainability

Advancing green practices that reduce the carbon footprint of clinical supplies while maintaining compliance and reliability.

Evolving Regulations

Explore practical approaches to regulatory compliance as regulatory expectations evolve in response to decentralised and adaptive trials, with greater focus on temperature control and end-to-end traceability.

Advanced Therapies

Explore the impact of advanced therapies on building future-ready clinical trial supply chains, including the unique requirements of cell and gene therapies, personalised medicines, and other complex, high-value treatments.

Join us to shape the next generation of clinical trial supplies, one that’s equipped to handle the complexities of tomorrow’s clinical landscape while maintaining a strong commitment to patient care, innovation, and environmental responsibility.

Transform Your CTS Chain:
Smarter, Faster, Greener Clinical Supply Strategies

Build A Smarter CTS Chain:
Explore How to Optimise Forecasting, Enhance Inventory Visibility, and Leverage Data-Driven Planning to Reduce Waste and Costs.

Develop A Faster CTS Chain:
Learn How to Improve Distribution Efficiency, Accelerate Time-to-Patient, and Streamline Global Operations for Complex Trials.

Create A Greener CTS Chain:
Discover Strategies to Implement Sustainable Packaging, Reduce Carbon Footprint, and Adopt Greener Transport and Storage Solutions

Learn more

Attendee Testimonials

"The forum was very effective. Good for information exchange and networking. Well organised event too with clear instructions and good balance of breaks for networking."

"Very valuable to get an insight what other companies are planning, what challenges they have and discuss possible solutions"

"Great value event, enjoyed networking and the latest thinking from like minded professionals"

"Round table discussions and networking was valuable. Very interesting talks and in discussions throughout the two days"

"Absolutely interesting and engaging"

"Very valuable, the workshops were useful and made good connections"

"The open atmosphere between the attendees is extremely helpful to learn from each other's experiences in the identification of efficient solutions "

"This event was a great learning opportunity for me. I think that it speaks volumes regarding the collaborative nature of the event, when someone like me (attending my first conference, with only 3.5 years' experience in CTS) felt comfortable enough to ask questions and participate in the discussions. "